26.09
전일 마감가:
$27.39
열려 있는:
$27.29
하루 거래량:
1.40M
Relative Volume:
0.89
시가총액:
$1.76B
수익:
$2.76B
순이익/손실:
$-358.70M
주가수익비율:
-5.2495
EPS:
-4.97
순현금흐름:
$-35.90M
1주 성능:
+3.12%
1개월 성능:
-9.63%
6개월 성능:
-42.92%
1년 성능:
-32.95%
Quidelortho Corporation Stock (QDEL) Company Profile
명칭
Quidelortho Corporation
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
QDEL
Quidelortho Corporation
|
26.09 | 1.85B | 2.76B | -358.70M | -35.90M | -4.97 |
![]()
ABT
Abbott Laboratories
|
126.35 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
105.84 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
400.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
91.97 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.49 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
2024-12-10 | 개시 | Jefferies | Hold |
2024-09-19 | 재개 | UBS | Neutral |
2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
2022-09-19 | 개시 | Citigroup | Neutral |
2022-07-20 | 개시 | UBS | Sell |
2022-06-17 | 재개 | JP Morgan | Neutral |
2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2018-10-23 | 재개 | Raymond James | Strong Buy |
2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-01-22 | 재확인 | Barclays | Overweight |
2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2017-04-25 | 재확인 | Canaccord Genuity | Hold |
2017-02-17 | 개시 | CL King | Neutral |
2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2016-02-18 | 재확인 | Barclays | Overweight |
2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2016-01-08 | 재확인 | Canaccord Genuity | Buy |
2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2015-09-02 | 개시 | Barclays | Overweight |
2013-07-31 | 재확인 | Canaccord Genuity | Buy |
2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corporation 주식(QDEL)의 최신 뉴스
QuidelOrtho Stock Faces Continued Downturn as Investors Await EarningsNews and Statistics - IndexBox
Why QuidelOrtho (QDEL) Shares Are Sliding Today - TradingView
What are analysts’ price targets for QuidelOrtho Corporation in the next 12 monthsDiscover investment plans that deliver results - jammulinksnews.com
How many analysts rate QuidelOrtho Corporation as a “Buy”High-impact stock picks - jammulinksnews.com
How QuidelOrtho Corporation stock reacts to Fed policy changesReliable High Profit Alerts - metal.it
What catalysts could drive QuidelOrtho Corporation stock higher in 2025Invest smarter with actionable market insights - jammulinksnews.com
Is QuidelOrtho Corporation a good long term investmentTriple-digit return opportunities - PrintWeekIndia
What drives QuidelOrtho Corporation stock priceRapidly expanding wealth - PrintWeekIndia
What analysts say about QuidelOrtho Corporation stockGame-changing returns - Autocar Professional
Can QuidelOrtho Corporation stock recover from recent declineExplosive returns - jammulinksnews.com
Is QuidelOrtho Corporation stock overhyped or has real potentialTremendous financial leverage - jammulinksnews.com
Emergency Drug Detection: How New Diagnostic Tests Are Saving Lives in Overdose Crisis - Stock Titan
QuidelOrtho Corporation Stock Analysis and ForecastFree Stock Market Forecast Reports - Autocar Professional
QuidelOrtho to Report Second Quarter 2025 Financial Results | QDEL Stock News - GuruFocus
QuidelOrtho to Report Second Quarter 2025 Financial Results - Stock Titan
QuidelOrtho and BÜHLMANN launch FCAL turbo and FPELA turbo assays on VITROS Systems - SelectScience
RBC Capital Maintains a Buy Rating on QuidelOrtho Corporation (QDEL), Sets a $60 PT - MSN
QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To Know - MSN
Real Labs, Actual Decisions With Actionable Six Sigma Metrics - The Malaysian Reserve
BPAS - FinancialContent
QuidelOrtho Announces Featured ADLM Session on Six Sigma Insights for Lab Performance - AInvest
Quidelortho Corporation (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):